Skip to main content
Caplight Logo









Pulmongene

Pulmongene

Private
BeijingHealthcare & Life Scienceshttps://www.pulmongene.com/

Company Overview

Pulmongene is a clinical-stage biotechnology company that develops first-in-class therapies for pulmonary, fibrotic, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryidiopathic pulmonary fibrosisIPFanti-fibrotic therapyclinical trialspulmonary fibrosisbiopharmaorgan fibrosistherapeutic antibodiesprogressive pulmonary fibrosisPPFclinical-stage biotechautoimmune diseasedrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pulmongene Comparables

Compare Pulmongene with similar companies based on industry and business-model similarity.

Pulmongene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Celea Therapeutics
83%
Endeavor BioMedicines
83%
Oorja Bio, Inc.
80%

Pulmongene Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Pulmongene Filings

Explore SEC and related filing metadata, where available.

Pulmongene filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pulmongene's valuation, stock price, and market status.

Is Pulmongene a public or private company?

Pulmongene is a private company.

What is the current stock price of Pulmongene?

Pulmongene is a private company with no public stock price. No recent secondary market data is available.

How much is Pulmongene worth (valuation)?

Valuation information for Pulmongene is not publicly available.

Can I buy Pulmongene stock?

Pulmongene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pulmongene's last funding round?

Funding round information for Pulmongene is not publicly available.

Who are the main investors in Pulmongene?

Investor information for Pulmongene is not publicly disclosed.

Will Pulmongene IPO soon?

No public IPO plans have been announced for Pulmongene.

How can I track Pulmongene secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pulmongene's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?